Back to top

Fulcrum Therapeutics (FULC) Receives a Sell from Bank of America Securities

In a report released today, Tazeen Ahmad from Bank of America Securities maintained a Sell rating on Fulcrum Therapeutics, with a price target of $...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Fulcrum Therapeutics, Inc. (FULC)